Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms?
Authors:
- 12 June 2021
- journal article
- research article
- Published by Springer Nature in Endocrine
- Vol. 74 (2) , 421-429
Abstract
Purpose Type III gastric neuroendocrine neoplasms (g-NENs) have historically been regarded as aggressive tumours, hence current guidelines advocate radical surgery with lymph node dissection. Data on the roles of endoscopic or less extensive surgical resections are more limited. The aim of our study is to evaluate the clinicopathological features and long-term outcomes of patients undergoing endoscopic or limited surgical resection for localised grade 1 or 2 type III g-NENs when compared to radical surgery. Methods Retrospective analysis of all patients diagnosed with a localised grade 1 or 2 type III g-NENs across six tertiary NEN centers between 2006 and 2019. Results Forty-five patients were diagnosed with a potentially resectable grade 1 or 2 type III g-NEN of whom 36 underwent either endoscopic or surgical resection. No statistically significant differences were found between the three resection groups in terms of patient age, tumour location, grade or size. Only tumour size was found to be significantly associated with poor clinical outcome (p = 0.012) and ROC curve analysis identified tumour size >10 mm as a negative predictor (AUC:0.8030, p = 0.0021). Tumours >10 mm were also more likely to be associated with lymph node metastases on imaging and histology (p = 0.039 and p = 0.026 respectively). Conclusions Localised grade 1 or 2 type III g-NENs had a good prognosis in this series. Tumour size >10 mm was the most significant prognostic factor affecting patient outcome. Endoscopic resection or limited surgical resection is feasible and safe in small type III g-NENs which demonstrate favourable grade 1/2, well differentiated histology.Keywords
This publication has 28 references indexed in Scilit:
- Endoscopic Ultrasound in Gastroenteropancreatic Neuroendocrine TumorsGut and Liver, 2012
- ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal NeoplasmsNeuroendocrinology, 2012
- Risk Factors for Disease Progression in Advanced Jejunoileal Neuroendocrine TumorsNeuroendocrinology, 2011
- Metastatic and Locally Advanced Pancreatic Endocrine Carcinomas: Analysis of Factors Associated With Disease ProgressionJournal of Clinical Oncology, 2011
- NANETS Treatment GuidelinesPancreas, 2010
- Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumoursEndocrine-Related Cancer, 2008
- Endoscopic resection of early gastric cancerGastric Cancer, 2007
- Review article: pathogenesis and management of gastric carcinoid tumoursAlimentary Pharmacology & Therapeutics, 2006
- Application of minimally invasive treatment for early gastric cancerJournal of Surgical Oncology, 2004
- Gastric Carcinoids and Neuroendocrine Carcinomas: Pathogenesis, Pathology, and BehaviorWorld Journal of Surgery, 1996